Neumora Therapeutics

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell NMRA and other ETFs, options, and stocks.

About NMRA

Neumora Therapeutics, Inc. is a clinical-stage biotechnology company. It offers a precision medicine approach for brain diseases through the integration of data science and neuroscience.

CEO

Paul L. Berns

CEOPaul L. Berns

Employees

110

Employees110

Headquarters

Watertown, Massachusetts

HeadquartersWatertown, Massachusetts

Founded

2019

Founded2019

Employees

110

Employees110

NMRA Key Statistics

Market cap

419.44M

Market cap419.44M

Price-Earnings ratio

-1.72

Price-Earnings ratio-1.72

Dividend yield

—

Dividend yield—

Average volume

3.92M

Average volume3.92M

High today

$2.71

High today$2.71

Low today

$2.54

Low today$2.54

Open price

$2.70

Open price$2.70

Volume

1.38M

Volume1.38M

52 Week high

$14.09

52 Week high$14.09

52 Week low

$0.611

52 Week low$0.611

Analyst ratings

50%

of 8 ratings

Buy

50%

Hold

37.5%

Sell

12.5%

People also own

Based on the portfolios of people who own NMRA. This list is generated using Robinhood data, and it’s not a recommendation.